Why Your Joints Changed Before Anything Else Did
Updated: Sep 20
Written by the Editorial Team.
A frozen shoulder that arrived from nowhere and a stiffness that outlasts the weather were dismissed as ordinary ageing for a decade too long. The editorial team explains the musculoskeletal syndrome of menopause: what the research actually found, why it gets missed, and what genuinely helps.
It usually starts with one joint. A shoulder that will not lift overhead, a hip that catches on the stairs, hands that feel stiff before the kettle has even boiled.
A GP examines it, finds nothing structurally wrong, and offers the explanation most women in their forties have heard before: you are getting older. For years, that was the end of the conversation.
More than 70 per cent of women will experience it. It was never named until 2024.
It has a name now, and a mechanism, and a number attached to it that makes the dismissal look like exactly what it was: a gap in medical attention, not a gap in the evidence.
The research that finally named it
In 2024, orthopaedic surgeon Vonda Wright and colleagues Jonathan Schwartzman, Rafael Itinoche and Jocelyn Wittstein published a review in the journal Climacteric that gave this pattern a formal clinical name for the first time: the musculoskeletal syndrome of menopause.
Their review estimated that more than 70 per cent of women experience musculoskeletal symptoms through the menopause transition, and around 25 per cent are disabled by them at some point, whether that means missed workouts, interrupted sleep, or an inability to lift a child or a suitcase without pain.
The syndrome covers joint pain, frozen shoulder, tendon pain, accelerated muscle loss and reduced bone density, all converging in the same hormonal window.
What makes it a syndrome rather than a collection of coincidences is the shared cause: as oestrogen falls, tissue that depends on it, cartilage, tendon, muscle, bone, loses support more or less simultaneously, which is why symptoms in several joints at once, rather than one worn-out joint, is such a characteristic pattern.
Frozen shoulder, the flagship complaint
Wright has described frozen shoulder as the single most common complaint she sees tied to this syndrome. It affects women roughly four times more often than men, and it clusters overwhelmingly between the ages of 40 and 60, the exact window of the menopause transition.
The shoulder joint's capsule and surrounding tendons carry a dense concentration of oestrogen receptors, so when oestrogen drops, that tissue loses elasticity and repair capacity at a rate other joints do not always match.
For many women, a frozen shoulder is also the first symptom serious enough to prompt a doctor's visit, which makes it something of an entry point into the wider syndrome rather than an isolated problem.
Why it keeps getting dismissed as ageing
Wright has been explicit that the timeline matters here. The decline in oestrogen, and with it the musculoskeletal changes that follow, typically begins in the forties, not the late fifties or sixties that the word ageing tends to conjure.
Women arriving at her clinic with unexplained shoulder or hip pain in their mid-thirties to early forties are often told, by others and sometimes by themselves, that this is simply what getting older feels like.
That framing has a cost. A woman who accepts unexplained joint pain as an inevitable fact of ageing is less likely to raise it with a clinician, less likely to be offered a hormonal explanation, and more likely to reduce her activity at precisely the point when movement is part of what protects her.
The tissue-level mechanism
Oestrogen is anti-inflammatory, and its receptors sit throughout the musculoskeletal system, in muscle, tendon, ligament, cartilage and the fascia that wraps all of it.
A 2025 systematic review of postmenopausal oestrogen deficiency and tendon degeneration, drawing on nineteen studies, found that falling oestrogen is associated with reduced tendon elasticity, altered load transfer and impaired healing capacity, with tenocytes, the cells that maintain tendon tissue, expressing oestrogen receptors that appear to regulate repair and limit fatty infiltration when oestrogen is present.
The same falling hormone also affects how joints are lubricated and how sensitively the nervous system registers pain, which is part of why morning stiffness and multi-joint aching are such consistent features of this transition rather than a single sore spot that would point to a local injury.
What hormone therapy can and cannot promise
The clearest trial evidence on hormone therapy and joint pain comes from the Women's Health Initiative, in an analysis of more than 10,000 postmenopausal women who had undergone a hysterectomy and were treated with oestrogen alone rather than combined oestrogen and progesterone.
At baseline, 77 per cent reported joint pain. After one year, joint pain was somewhat less frequent in the oestrogen group than the placebo group, 76.3 per cent versus 79.2 per cent, and that modest gap persisted at three years, 74.2 per cent versus 79.8 per cent.
That is a real but modest effect, in a specific population, using oestrogen-only therapy rather than the combined therapy most women with a uterus require.
It is not evidence that hormone therapy resolves joint pain for everyone, and the decision to start it depends on individual medical history, risk factors and a proper clinical conversation rather than on this syndrome alone.
Telling it apart from osteoarthritis
The distinction matters because the two conditions respond to different approaches. Osteoarthritis typically affects weight-bearing joints asymmetrically and tends to worsen with activity.
Menopause-related joint pain more often appears in several joints at once, responds to movement rather than being worsened by it, and can fluctuate in step with hormonal shifts rather than following a steady mechanical decline.
Neither pattern is a self-diagnosis tool. The value of knowing the distinction is knowing which questions to bring to an appointment, and knowing that a clinician dismissing multi-joint, symmetric, movement-responsive pain as simple wear and tear may be missing the more likely explanation.
What actually helps
The most consistent evidence points toward combined aerobic and resistance exercise, the same combination that protects bone density and muscle mass through this transition for entirely separate reasons.
Movement that loads tendon and muscle in a controlled way appears to support the same tissue that oestrogen loss is undermining, which is part of why low-impact, joint-conscious strength work earns a place here rather than complete rest.
Sleep quality also plays a measurable role, since poor sleep independently increases pain sensitivity, and anti-inflammatory nutrition and weight management reduce mechanical load on affected joints.
None of these are cures. They are the levers with the strongest evidence behind them, used alongside medical guidance rather than instead of it.
What this changes
Naming a syndrome does not remove the pain, but it removes something else that had been quietly compounding it: the sense that a woman is imagining a problem her body is demonstrably having.
A name gives a clinician a framework to work from and gives a woman the language to ask a more specific question than 'is this normal', one that can actually be investigated and treated.
Understanding what is happening in the body is itself a form of Calm Power, the steadiness that comes from clarity rather than from pushing through.
That steadiness is what makes it possible to advocate for the right care, rather than quietly absorbing pain as the price of getting older.
What's next
For the movement side of this picture, read Burnout, Menopause, or Both: 8 Signals That Tell Women What Their Body Is Doing, on telling hormonal signals from occupational ones.
Then explore our Menopause collection for more evidence-based perspectives on this transition.
For the wider picture on energy, sleep and hormones after 40, explore our Lifestyle Medicine for Women 40+ resource.
Ready to understand your current recovery needs more precisely?
The Free Calm Power Assessment at Calmfidence World maps where you are now and what your body may need most.
FAQ
What exactly is the musculoskeletal syndrome of menopause?
It is the clinical name, established by Vonda Wright and colleagues in a 2024 Climacteric review, for the cluster of joint pain, frozen shoulder, tendon pain, muscle loss and bone density loss that affects more than 70 per cent of women through the menopause transition, driven by falling oestrogen across muscle, tendon, cartilage and bone at the same time.
Practical step: if you are experiencing pain in more than one joint since your forties began, mention the term to your GP by name.
Is this just normal ageing?
No, not in the way the word ageing usually implies. The changes typically begin in the forties, driven specifically by declining oestrogen, rather than being a slow, steady mechanical wear that accumulates evenly over decades.
Practical step: if joint pain arrived relatively suddenly rather than gradually over many years, raise the hormonal explanation specifically rather than accepting a general ageing explanation.
Does hormone replacement therapy help joint pain?
The clearest trial evidence, from the Women's Health Initiative, found a modest but real reduction in joint pain frequency among postmenopausal women taking oestrogen-only therapy compared with placebo, sustained over three years. The effect was real but modest, and was measured in a specific population, so it is not evidence that hormone therapy resolves joint pain for every woman.
Practical step: ask your clinician specifically what hormone therapy is likely to change for your joint symptoms, rather than assuming it will resolve them.
Should I stop exercising when my joints hurt?
Generally no. The evidence points toward combined aerobic and resistance exercise as one of the strongest available supports for this syndrome, since controlled loading appears to help the same tendon and muscle tissue that oestrogen loss is undermining, rather than making it worse.
Practical step: reduce intensity or impact during a flare rather than stopping movement altogether, and favour low-impact strength work.
Which kind of movement is safe during a flare?
Low-impact, controlled-range movement, such as Yogilates, Barre, swimming or gentle resistance work, tends to be better tolerated than high-impact or ballistic exercise during an active flare, since it loads tissue without the jarring that aggravates irritated joints.
Practical step: mention any current flare to an instructor before class so movements can be modified rather than avoided altogether.
Who should take medical advice about this?
Anyone experiencing new or worsening multi-joint pain, frozen shoulder symptoms, or unexplained stiffness in their forties or fifties, particularly if it is affecting sleep, work or daily movement, should raise it with a doctor and ask specifically about hormonal causes.
Practical step: bring a written note of which joints are affected and when the pain began to your appointment, since that pattern is itself diagnostically useful.
Curious to explore more?
Sign up and join the Calmfidence Circle, high-achieving women 40+ exploring emotional health, sustainable performance and regeneration.
Calmfidence World. From depletion to Calm Power.
